• Home
  • News
    • Pre-Meeting
    • Meeting Coverage
    • Post-Meeting
    • Poster Presenters 2024
    • Archives
      • 2023
      • 2022
      • 2021
      • 2020
      • 2019
      • 2018
      • 2017
  • Map & Photos
  • Industry
    • Industry Events
      • Featured Industry Events
      • Innovation Theaters
      • Industry-Supported Symposia
      • Lightning Talks
    • Industry Connections
  • Publications
    • Preview Edition Newspaper
    • Meeting Magazine
  • App & Planner
  • Schedule
  • Resources
    • App & Planner
    • Schedule
  • Follow Us
    • X (Twitter)
    • Facebook
    • LinkedIn
    • YouTube
  • Subscribe
Meeting Home

The official news source of ACR Convergence 2024

Watch On Demand
  • Phase 2 AMP data provide insight into molecular landscape of lupus

    Phase 2 AMP data provide insight into molecular landscape of lupus

    November 9, 2021

    Researchers from the Accelerating Medicines Partnership SLE Consortium reported phase 2 results during a Sunday morning session.

  • Plenary II: Results from six highly anticipated studies reported

    Plenary II: Results from six highly anticipated studies reported

    November 9, 2021

    During Sunday morning’s Plenary II session, researchers reported results from the VITAL trial, ORAL Surveillance, and STOP-JIA, among others.

  • Gluck lecturer discusses emerging therapies targeting the role of bone in OA

    Gluck lecturer discusses emerging therapies targeting the role of bone in OA

    November 9, 2021

    In Sunday’s Oscar S. Gluck, MD Memorial Lecture, Marc Hochberg, MD, MPH, described research into the pathogenesis and progression of OA that has helped identify new targets for therapeutic intervention.

  • ARP lecturer describes link between employment, poverty, and rheumatic diseases

    ARP lecturer describes link between employment, poverty, and rheumatic diseases

    November 9, 2021

    Musculoskeletal conditions, particularly rheumatic diseases like RA and lupus, are among the most common causes of employment problems, according to Edward H. Yelin, PhD, who delivered Sunday’s ARP Distinguished Lecture.

  • FDA representatives provide updates on drug approvals, safety issues

    FDA representatives provide updates on drug approvals, safety issues

    November 9, 2021

    The FDA has been busy during the COVID-19 pandemic, with emergency use authorizations for two rheumatology agents, approvals for new agents, and new indications and safety warnings for both prescription and OTC medications.

  • Experts review diagnostic imaging, treatment options for osteoporosis

    Experts review diagnostic imaging, treatment options for osteoporosis

    November 9, 2021

    During a Monday session, Amanda Crawford, CRNP, CCD, and Saba Mohiuddin, PharmD, BCACP, discussed the management of osteoporosis, with a special focus on diagnostic imaging and pharmaceutical interventions.

Upcoming Featured Industry Events

View All

View Archives

  • Select Year
    • 2017
    • 2018
    • 2019
    • 2020
    • 2021
    • 2022
    • 2023

Popular Articles

  • Daltroy Lecture Examines the Psychological Impacts of Living with Rheumatic Disease


  • ARP Distinguished Lecture: Better Understanding of AI Will Enhance Its Utility for Rheumatologists


  • FDA Gives Updates on Newly Approved Agents for Rheumatic Diseases


  • Clinicians Discuss Experience Using Ambient Listening Technology in Clinical Practice


  • Opening Session Keynote Spotlights the Crucial Role of Allyship in Rheumatology



@2024 American College of Rheumatology. All Rights Reserved. Powered by TriStar Event Media, LLC

Privacy Policy